The Mixed Lineage Kinase-3 Inhibitor URMC-099 Improves Therapeutic Outcomes for Long-Acting Antiretroviral Therapy

During studies to extend the half-life of crystalline nanoformulated antiretroviral therapy (nanoART) the mixed lineage kinase-3 inhibitor URMC-099, developed as an adjunctive neuroprotective agent was shown to facilitate antiviral responses. Long-acting ritonavir-boosted atazanavir (nanoATV/r) nano...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nanomedicine
Egile Nagusiak: Zhang, Gang, Guo, Dongwei, Dash, Prasanta K., Araínga, Mariluz, Wiederin, Jayme L., Haverland, Nicole A, Knibbe-Hollinger, Jaclyn, Martinez-Skinner, Andrea, Ciborowski, Pawel, Goodfellow, Val S., Wysocki, Tadeusz A., Wysocki, Beata J., Poluektova, Larisa Y., Liu, Xin-Ming, McMillan, JoEllyn M., Gorantla, Santhi, Gelbard, Harris A., Gendelman, Howard E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728028/
https://ncbi.nlm.nih.gov/pubmed/26472049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2015.09.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak